It was reported the patient is experiencing increased pain at the lead site wherein a drg lead fragment remains implanted in the patient which could not be retrieved from a previous explanation.No intervention is planned at this time.The results of the investigation are inconclusive since the devices were not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.Please note this report submission is not late.The report is resubmitted per the request from the fda, due to missing 3rd acknowledgement.This is caused by an fda esg server issue from (b)(6) 2022.This issue is documented in help ticket (b)(4).The initial submission attempt was performed on (b)(6) 2022.
|